Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 - WTVM.com-Columbus, GA News Weather & Sports

Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer



 

 

 

LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

http://www.reportbuyer.com/pharma_healthcare/medical_devices/coronary_stents_emerging_markets_brazil_russia_india_china_south_africa_south_korea_2009_2015.html

Global Market Watch:
BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents and …etc. China accounts for nearly 28% of the market share and India claims more than 23%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Drug Eluting Stents account more nearly half of the market value while Absorbable Stents segments indicate a close 15%. In case of Stent Coating, Polymer depicts the largest CAGR while Non-Polymer and Inorganic in second and third place respectively.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.


Report Focus:
The report 'Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:

• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies


The analysis primarily deals with by type & stent coating. Further, the subdivided categories include:
Coronary Stents – By Type & Stent Coating
- By Type
a. Drug-Eluting Stents (DES)
b. Bare Metal Stents (BMS)
c. Absorbable Stents/Biodegradable Metallic Stent
d. Anti-Restenosis Devices
i. Bioactive Stent
ii. Radioactive Stent
iii. Drug-Eluting Balloon
- By Stent Coating
a. Inorganic (PERSE, Gold, Silicon Carbide, Iridium Oxide, Carbon, Titanium-Nitride-Oxide)
b. Polymer (Biodegradable & Non-Biodegradable)
c. Non-Polymer (Microporous, Microstructured, Slotted Tubular, Nanoporous, Nanopatterned)
d. Other Coatings (Heparin, Hyaluronic Acid, Fibrin), Technologies & R&D

The period considered for the coronary stents market analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil, Russia, India, China, South Korea and South Africa).

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

I. REPORT FOCUS
A. INTRODUCTION

CARDIOLOGY

KINDS OF CARDIAC CONDITIONS
A. BLOOD FLOW IN THE HEART

B. HEART MALFUNCTION
TYPES OF CARDIAC ARREST

C. MYOCARDIUM
DISORDERS OF MYOCARDIUM

D. PERICARDIUM

E. HEART VALVES
DISORDERS OF HEART VALVES

F. CONGENITAL HEART DEFECT
TYPES OF CONGENITAL HEART DEFECT

G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)

H. HEART FAILURE

B. CARDIOVASCULAR DEVICES
DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
TOOLS DEPLOYED IN CARDIOLOGY
DIAGNOSTIC TESTS AND PROCEDURES
CONCLUSION

C. INTERVENTIONAL CARDIOLOGY

A. INTERVENTIONAL DIAGNOSTICS AND ITS TECHNOLOGIES
I. INTRAVENOUS ULTRASOUND (IVUS)
II. OPTICAL COHERENCE TOMOGRAPHY (OCT)
III. FRACTIONAL FLOW RESERVE (FFR) - A BIG TECHNOLOGICAL BREAKTHROUGH
IMPLICATIONS OF FFR GROWTH - FALL IN USE OF GUIDEWIRES AND DES IN PATIENTS WITH MULTIVESSEL STENOSES
FFR HAS GREATER IMPACT ON THE GLOBAL MARKET IN THE LONG TERM
EMERGING RIVAL TECHNOLOGIES: CT-FFR AND IFR
THE RESULTS OF A CLINICAL TRIAL COMPARING IFR TO FFR
PERCUTANEOUS CORONARY INTERVENTION (PCI)

B. INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS

ADVANCES IN STENT TECHNOLOGY: EXPECTATIONS AND NEW DEVELOPMENTS
STENT SCAFFOLD STRUCTURE

CORONARY STENT COATING TYPES - IN BRIEF
TYPES OF STENT COATINGS, IN BRIEF:-

A. INORGANIC COATINGS
GOLD
SILICON CARBIDE
IRIDIUM OXIDE
CARBON
TITANIUM-NITRIDE-OXIDE

B. POLYMER COATINGS
NON-BIODEGRADABLE POLYMERS
BIODEGRADABLE POLYMERS

C. NON-POLYMER COATINGS/SURFACES:
MICROPOROUS SURFACES
MICROSTRUCTURED SURFACES
SLOTTED TUBULAR SURFACES
NANOPOROUS SURFACES
NPS
NANO-PATTERNED SURFACES

D. OTHER COATINGS/STRATEGIES
HEPARIN
HYALURONIC ACID (HA)
FIBRIN
ENDOTHELIAL CELLS (EC)
CONCLUSION

CARDIAC STENT USAGE IN THE US
PROCEDURES PERFORMED
PREFERRED STENT TYPE
STENT FACTORS AND THE IMPORTANCE OF VENDOR RELATIONSHIPS

A. DRUG-ELUTING STENTS (DES)
DIAGNOSTICS LIKELY TO CHANGE DES USAGE
INTRAVENOUS DIAGNOSTICS: THE FUTURE GATEKEEPER FOR STENT USAGE
DES: THE NEXT TARGET FOR MEDICAL SPENDING CUTS
DES AT THE FOREFRONT OF PRICE CUTS AND USAGE LIMITATION
ASIAN-BORN INNOVATION TO TARGET A DECLINING DES MARKET IN FUTURE
THE BEST STENTS AVAILABLE IN MARKET AND INNOVATIONS ARE ON THE WAY
GROWTH TREND OF ASIAN COMPANIES COMPARABLE TO US COMPANIES' IN THE LATE 90'S
US AND JAPAN BREAKDOWN OF PCI CASES
GLOBAL DRUG-ELUTING STENT MARKET LIKELY TO DECLINE
NEXT GENERATION STENTS - BVS, SYNERGY, TCD-10023 AND BIOFREEDOM
FIRST-GENERATION STENTS
SECOND-GENERATION STENTS
THIRD-GENERATION STENTS

B. BARE METAL STENTS (BMS)
BARE-METAL AND DRUG-ELUTING STENTS MARKET

C. ABSORBABLE STENTS/BIODEGRADABLE METALLIC STENT
BIOABSORBABLE STENT SCAFFOLDS
SELF-EXPANDING STENT SCAFFOLDS
MICROMESH COVERED STENT
DEDICATED BIFURCATION STENTS
SPECULATION ON BIO-ABSORBABLE STENTS

D. ANTI-RESTENOSIS DEVICES
VASCULAST™ - DRUG ELUTING COATING
COVIDIEN COMMENCES PATIENT ENROLMENT IN ANTI-RESTENOSIS STUDY
DRUG ELUTING BALLOONS
CONCLUSION

NEW DIRECTIONS FOR STENT TECHNOLOGY
STRONG GROWTH EXPECTED FOR BIOABSORABLE STENTS IN EUROPE, UNITED STATES
BIOSENSORS, ABBOTT, ART EMERGE AS BIOABSORABLE STENT COMPETITORS
BIFURCATED STENTS TO ENTER THE U.S. MARKET, EUROPEAN MARKET SEES DOUBLE DIGIT GROWTH

D. CORONARY STENTS - TYPES & STENT COATING - MARKET BRIEFING
CHINA
INDIA
BRAZIL
RUSSIA
SOUTH KOREA
SOUTH AFRICA

II. MARKET ANALYSIS
CORONARY STENTS – BRICSS – INDUSTRY SNAPSHOT

A. CORONARY STENTS - SEGMENTATION
CORONARY STENTS - GLOBAL
CORONARY STENTS - BRICSS

CORONARY STENTS – BY TYPE
CORONARY STENTS - BRICSS - BY TYPE
DRUG-ELUTING STENTS (DES)
BARE METAL STENTS (BMS)
ABSORBABLE STENTS
ANTI-RESTENOSIS DEVICES

CORONARY STENTS - BY STENT COATING
CORONARY STENTS - BRICSS - BY STENT COATING
INORGANIC COATING
POLYMER COATING
NON-POLYMER COATING
OTHER STENT COATINGS

B. GROWTH RATE ANALYSIS
BRICSS CORONARY STENTS - MARKET GROWTH RATES
BRICSS CORONARY STENTS - TYPE - GROWTH RATES
BRICSS CORONARY STENTS - STENT COATING - GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW
FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS

A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
CARDIAC RHYTHM MANAGEMENT DEVICES
CRM IN EUROPE

CARDIAC DEFIBRILLATORS
RAPID GROWTH IN DEFIBRILLATOR SALES

CARDIAC PACEMAKER DEVICES
THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT)

CARDIAC MONITORING AND DIAGNOSTIC DEVICES
THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW

INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS
EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION

FFR IMPACT ON DES MARKET
MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET

CARDIAC CATHETERS
COMPETITIVE ANALYSIS

ELECTROPHYSIOLOGY CATHETERS (EP)
GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH

EP MAPPING
NEW AF ABLATION DEVICES SEEK APPROVAL

ATRIAL FIBRILLATION (AF)

INTRAVASCULAR ULTRASOUND (IVUS)
GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS

PERIPHERAL VASCULAR DEVICES
ARTERIOTOMY CLOSURE DEVICES
EMBOLIC PROTECTION DEVICES (EPD)
INFERIOR VENA CAVA (IVC) FILTERS
CONCLUSION

PERIPHERAL GUIDEWIRES
AV ACCESS THROMBECTOMY DEVICES

PROSTHETIC HEART VALVES
SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
MARKET CHALLENGES

B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
SIZE AND WEIGHT
POWER EFFICIENCY
PERFORMANCE SPECIFICATIONS
RISK MITIGATION AND RELIABILITY
EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
IMPACT OF CVD IN EUROPE
IMPACT ON NEW YORK STATE
ECONOMIC IMPACT OF CVD IN NYS
HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
IMPACT OF CVD ON ECONOMIC STABILITY

ECONOMIC COST OF CARDIOVASCULAR DISEASES

COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030

CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE

D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND

E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES

F. MARKET TRENDS
PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER.
AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
MORTARA INSTRUMENT, INC. LAUNCHES "BUILT WITH PRIDE IN MILWAUKEE" CAMPAIGN.
MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
DRUG-ELUTING STENTS ARE SECURE
CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.
HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE "MOST ADMIRED COMPANY"
BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY-INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
ZOLL NOMINATED TO GLOBE 100 AGAIN
USCOM ENTERS EUROPEAN MARKETS
POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
USCOM SECURES STRONG PRESENCE IN US AND CANADA
CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT
CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
USCOM EYES EASTERN EUROPEAN MARKET
VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
INFECTIONS FROM IMPLANTED CARDIAC DEVICES
TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
HEART TRANSPLANTS SUBSTITUTED BY A PUMP
DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
REMOTE MONITORING OF HEART FAILURE PATIENTS
EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
OVER-THE-COUNTER APPARATUS
BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR
CARDIAC SCIENCE'S NEW CARDIAC TREATMENT
THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
BEST AND LATEST SELF-TEACHING HEART SOUNDS
REPLACING VALVE WITHOUT CARDIAC SUPPORT
U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS

G. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES

CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS

CARDIAC MEDICAL DEVICES – PATENTS

KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX
RESEARCH FOCUS
ABOUT AXIS RESEARCH MIND
DISCLAIMER
FEEDBACK



Read the full report:
Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

http://www.reportbuyer.com/pharma_healthcare/medical_devices/coronary_stents_emerging_markets_brazil_russia_india_china_south_africa_south_korea_2009_2015.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

1909 Wynnton Road
Columbus, Ga. 31906

FCC Public File
publicfile@wtvm.com
706-494-5400
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and WTVM. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.